| CAR T-cell Therapy: A New Era in Cancer Immunotherapy AN Miliotou, LC Papadopoulou Current pharmaceutical biotechnology 19 (1), 5-18, 2018 | 545 | 2018 |
| In vitro-transcribed (IVT)-mRNA CAR therapy development AN Miliotou, LC Papadopoulou Chimeric Antigen Receptor T Cells: Development and Production, 87-117, 2020 | 30 | 2020 |
| Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders AN Miliotou, IS Pappas, G Spyroulias, E Vlachaki, AS Tsiftsoglou, ... Molecular Therapy-Nucleic Acids 26, 694-710, 2021 | 23 | 2021 |
| Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeutics IS Vizirianakis, AN Miliotou, GA Mystridis, EG Andriotis, II Andreadis, ... Expert Review of Precision Medicine and Drug Development, 1-13, 2019 | 22 | 2019 |
| Rapid on-site diagnosis of canine giardiosis: time versus performance I Symeonidou, AΙ Gelasakis, AN Miliotou, A Angelou, KV Arsenopoulos, ... Parasites & Vectors 13, 1-10, 2020 | 16 | 2020 |
| Chimeric Antigen Receptor T Cells K Swiech, KCR Malmegrim, V Picanço-Castro Springer, 2020 | 14 | 2020 |
| In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations GC Kaiafas, D Papagiannopoulou, ΑN Miliotou, AS Tsingotjidou, ... Molecular Genetics and Metabolism Reports 25, 100683, 2020 | 12 | 2020 |
| Delivering active molecules to the eye; the concept of electrospinning as potent tool for drug delivery systems PI Siafaka, EÖ Bülbül, AN Miliotou, ID Karantas, ME Okur, NÜ Okur Journal of Drug Delivery Science and Technology 84, 104565, 2023 | 10 | 2023 |
| Protein transduction domain-mediated delivery of recombinant proteins and in vitro transcribed mRNAs for protein replacement therapy of human severe genetic mitochondrial … AN Miliotou, PF Foltopoulou, A Ingendoh-Tsakmakidis, AS Tsiftsoglou, ... Pharmaceutics 15 (1), 286, 2023 | 6 | 2023 |
| An updated review for hyperuricemia and gout management; special focus on the available drug delivery systems and clinical trials ID Karantas, AN Miliotou, PI Siafaka Current Medicinal Chemistry, 2024 | 5 | 2024 |
| PTD-mediated delivery of α-globin chain into Κ-562 erythroleukemia cells and α-thalassemic (HBH) patients’ RBCs ex vivo in the frame of Protein Replacement Therapy AN Miliotou, D Papagiannopoulou, E Vlachaki, M Samiotaki, D Laspa, ... Journal of Biological Research-Thessaloniki 28, 1-13, 2021 | 5 | 2021 |
| Effect of the triphenylphosphonium cation on the biological properties of new rhenium and technetium-99m fac-[M (CO) 3 (NSN)]±-type complexes: Synthesis, structural … A Kyriazopoulos, AL Alexiou, A Miliotou, L Papadopoulou, ... Inorganica Chimica Acta 511, 119807, 2020 | 5 | 2020 |
| Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues NÜO Panoraia I. Siafaka, Ece Özcan Bülbül, Androulla N. Miliotou, Ioannis D ... Journal of Drug Delivery Science and Technology, 2024 | 4 | 2024 |
| An Innovative PTD-IVT-mRNA Delivery Platform for CAR Immunotherapy of ErbB(+) Solid Tumor Neoplastic Cells SK Georgiou-Siafis, AN Miliotou, C Ntenti, IS Pappas, LC Papadopoulou Biomedicines 10 (11), 2885, 2022 | 4 | 2022 |
| In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of Twenty-First Century: Exploitation of Peptides as Carriers for Their Intracellular Delivery AN Miliotou, IS Pappas, IS Vizirianakis, LC Papadopoulou urga, S., Barciszewski, J. (eds) Messenger RNA Therapeutics. RNA …, 2022 | 4 | 2022 |
| Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape AN Miliotou, SK Georgiou-Siafis, C Ntenti, IS Pappas, LC Papadopoulou Current Issues in Molecular Biology 45 (11), 9181-9214, 2023 | 3 | 2023 |
| Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells T Kakafika, Lyta, Gavriilidis, Tsiftsoglou, Miliotou, Pappas, Vizirianakis ... International Journal of Oncology 64, 42, 2024 | 2* | 2024 |
| An ATM/CHK2 Signaling Pathway Induces Nuclear Translocation of SRPK2 in Cisplatin-Treated HeLa Cells I Sigala, A Koukiali, A Miliotou, P Lougiaki, T Giannakouros, E Nikolakaki Processes 9 (12), 2223, 2021 | 2 | 2021 |
| Correction to: In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development AN Miliotou, LC Papadopoulou Chimeric Antigen Receptor T Cells: Development and Production, C1-C1, 2020 | 2 | 2020 |
| Synthesis and biological evaluation of 99mTc-tricarbonyl complexes of C-3 carboxy derivatives of fluoroquinolones in infection and tumor animal models DP Georgios Tzovas, Nafsika Papadimitriou, Eirini Angelakarou, Georgia ... Inorganica Chimica Acta, 2023 | 1* | 2023 |
Lefkothea PapadopoulouAristotle University of Thessaloniki, Thessaloniki, 54642, Macedonia, GREECE在 pharm.auth.gr 的电子邮件经过验证
